Tag: Technology

Study: Patients prefer online postop care to in-person care

Editor's Note In this pilot study of 50 surgical patients from Vanderbilt University Medical Center, Nashville, the majority preferred online postoperative visits to in-person visits. Online visits were accepted by patients and surgeons, took less time, and effectively identified patients who required further care.    

Read More

By: Judy Mathias
September 23, 2015
Share

ECRI Institute offers new robotic surgery planning service

Editor's Note ECRI Institute is offering a new robotic surgery planning service that gives hospitals an independent second opinion when starting or expanding a robotic surgery program.  The service focuses on:  Strategic planning  Quality and training  Financial assessment.   The high costs, risks, and questionable patient outcomes associated with robotic…

Read More

By: OR Manager
August 21, 2015
Share

Characteristics of total hips linked to early revision

Editor's Note Characteristics of total hip replacements (THRs) were found to be related to early prosthetic revision in this French study.  Antibiotic-free cemented and antibiotic-impregnated cemented THRs were compared with uncemented. Ceramic-on-ceramic, ceramic-on-polyethylene, and metal-on-metal THRs were compared with metal-on-polyethylene.  The antibiotic-impregnated cemented THRs had a better prognosis than uncemented,…

Read More

By: OR Manager
August 21, 2015
Share

Security issues prompt FDA to extend UDI deadlines

Editor's Note Security issues have prompted the Food and Drug Administration to extend the deadline from September 24 to October 24, 2015, for filing required data and labeling information for the Unique Device Identification system (UDI). The extension applies to implantable life-supporting and life-sustaining devices as well as Class III…

Read More

By: OR Manager
August 19, 2015
Share

Learn from hybrid OR experts at annual conference Town Hall

The interactive hybrid OR exhibit that debuted at the 2014 OR Manager Conference will once again be showcased in 2015. The exhibit, featuring an extensive array of products and equipment representing more than 10 companies, will be on display during the annual OR Manager Conference, October 7-9, at the Gaylord…

Read More

By: OR Manager
August 17, 2015
Share

High risk devices backed by few studies before and after FDA premarket approval

Editor's Note Many high risk therapeutic devices receive Food and Drug Administration (FDA) premarket approval with few studies to back their safety and efficacy, Yale researchers find. Studies of how the devices perform once on the market also are few. Of 28 high risk devices that received premarket approval between…

Read More

By: OR Manager
August 14, 2015
Share

FDA: Serious adverse events associated with LVADs

Editor's Note The Food and Drug Administration on August 5 issued a Safety Communication on serious adverse events linked to left ventricular assist devices (LVADs). Two implantable LVADs are approved by the FDA (HeartMate II by Thoratec Corporation and HeartWare HVAD by HeartWare Inc), and serious events have been associated…

Read More

By: OR Manager
August 6, 2015
Share

FDA releases supplemental measures for duodenoscope reprocessing

Editor's Note The Food and Drug Administration on August 4 released a Safety Communication that contains supplemental measures to enhance duodenoscope reprocessing. The measures emerged from an expert panel meeting earlier this year. In addition to following manufacturer reprocessing instructions, the FDA says facilities can use one or more of…

Read More

By: OR Manager
August 4, 2015
Share

Study: Cardiac CT angiography damages DNA

Editor's Note Patients exposed to radiation during cardiac computed tomographic angiography had evidence of deoxyribonucleic acid (DNA) damage that was associated with cell death, DNA damage in cells, and activation of genes involved in DNA repair, in this study. Most cells damaged by the CT scan were repaired, but a…

Read More

By: OR Manager
July 24, 2015
Share

Spine device market to reach $6.4B by 2024

Editor's Note A report by Q2 Metrics predicts the US market for spinal implants will reach $6.4 billion by 2024, up from $5 billion this year. The largest product segments include posterior thoracolumbar pedicle screw fixation and traditional anterior cervical plating. There is also strong momentum in hospital and physician…

Read More

By: OR Manager
July 22, 2015
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat